Evaluation of Symphony™ Posterior Cervical System for Surgical Treatment of Adult Cervical Deformity

Study Purpose

Multi-center, prospective, non-randomized study to evaluate Symphony™ Posterior Cervical System in the setting of surgical treatment of adult cervical deformity.

Recruitment Criteria

Accepts Healthy Volunteers

Healthy volunteers are participants who do not have a disease or condition, or related conditions or symptoms

No
Study Type

An interventional clinical study is where participants are assigned to receive one or more interventions (or no intervention) so that researchers can evaluate the effects of the interventions on biomedical or health-related outcomes.


An observational clinical study is where participants identified as belonging to study groups are assessed for biomedical or health outcomes.


Searching Both is inclusive of interventional and observational studies.

Observational
Eligible Ages 18 Years and Over
Gender All
More Inclusion & Exclusion Criteria

Inclusion Criteria:

1. ≥18 years old at time of treatment. 2. Patient undergoing a posterior cervical instrumented fusion using the DePuy Synthes SymphonyTM OCT System for the treatment of adult cervical deformity, defined as any of below criteria: 1. 10 degrees of overall cervical kyphosis (measured from C2-C7) 2. 10 degrees of kyphosis across any 1 or 2 cervical segments. 3. 10 degrees of scoliosis. 4. C2-C7 SVA >4cm. 3. Plan for surgical correction of cervical deformity in the next 6 months. 4. Willing to provide consent and complete study forms at baseline and follow-up intervals.

Exclusion Criteria:

1. Active spine tumor or infection. 2. Deformity due to acute trauma. 3. Unwilling to provide consent or to complete study forms. 4. Prisoner. 5. Pregnant or immediate plans to get pregnant

Trial Details

Trial ID:

This trial id was obtained from ClinicalTrials.gov, a service of the U.S. National Institutes of Health, providing information on publicly and privately supported clinical studies of human participants with locations in all 50 States and in 196 countries.

NCT04912674
Phase

Phase 1: Studies that emphasize safety and how the drug is metabolized and excreted in humans.

Phase 2: Studies that gather preliminary data on effectiveness (whether the drug works in people who have a certain disease or condition) and additional safety data.

Phase 3: Studies that gather more information about safety and effectiveness by studying different populations and different dosages and by using the drug in combination with other drugs.

Phase 4: Studies occurring after FDA has approved a drug for marketing, efficacy, or optimal use.

Lead Sponsor

The sponsor is the organization or person who oversees the clinical study and is responsible for analyzing the study data.

International Spine Study Group Foundation
Principal Investigator

The person who is responsible for the scientific and technical direction of the entire clinical study.

Justin Smith, MD, PhDChristopher Shaffrey, MDShay Bess, MD
Principal Investigator Affiliation University of VirginiaDuke UniversityDenver Int'l Spine Center, Rocky Mountain Hospital for Children & Presbyterian St. Luke's MC
Agency Class

Category of organization(s) involved as sponsor (and collaborator) supporting the trial.

Other, Industry
Overall Status Recruiting
Countries United States
Conditions

The disease, disorder, syndrome, illness, or injury that is being studied.

Cervical Deformity
Additional Details

Specific Aims:

  • - Evaluate outcomes for operative treatment of adult cervical deformity patients treated with posterior spinal fusion using SymphonyTM posterior cervical system at 6 weeks, 1 year, and 2 year follow up.
Outcome metrics will include standardized patient reported outcome measures, radiographic analysis of deformity correction and spinal alignment.
  • - Evaluate rates and risk factors for perioperative complications and need for revision surgery at 6 weeks, 1 year, and 2 years postoperatively.
  • - Develop and validate a surgical invasiveness index for cervical deformity surgical procedures.
  • - Validate the cervical deformity frailty index previously developed by the ISSG and further optimize this index.
  • - Establish adult cervical deformity specific thresholds for minimal clinically important difference (MCID) for standard outcomes measures using a patient satisfaction anchor.
  • - Develop a series of predictive models for adult cervical deformity surgery, including outcomes (e.g. overall change and achievement of MCID), occurrence of complications, and radiographic changes.
  • - Assess the psychological impact of adult cervical deformity, how psychological measures change following surgical treatment, and whether there are correlations between baseline psychological factors and outcomes following surgery.
  • - Assess baseline functional measures (e.g. grip strength) for adult cervical deformity patients presenting for surgery, assess how these functional measures change following surgery, and assess whether there are correlations between baseline functional measures and likelihood to improve following surgery.
  • - Assess baseline narcotic use among adult cervical deformity patients presenting for surgery.
  • - Assess changes in narcotic use from baseline to follow-up intervals after surgical treatment for adult cervical deformity.
  • - Assess for correlations between narcotic use (baseline and follow-up) and outcomes following surgical treatment for adult cervical deformity.
  • - Assess the impact of osteopenia and osteoporosis on patient frailty, complications, and maintenance of deformity correction.
  • - Define clinical and demographic features of the population afflicted with cervical deformity (e.g., age, gender, comorbidities, disability, health-related quality of life) - Assess for correlations between radiographic parameters and degree of disability/pain at baseline.
  • - Assess and describe surgical strategies used to address cervical deformity.
  • - Define complications and rates of complications (perioperative and delayed) associated with the surgical treatment of cervical deformity.
  • - Assess the role/need for pre/post operative tracheostomy and PEG.
  • - Evaluate and compare radiographic changes of sagittal spinal alignment (focal, regional, and global) and pelvic parameters pre and post cervical deformity surgery.
  • - Develop predictive formulas of post-operative alignments based on surgical techniques employed for correction.
  • - Identify risk factors related to poor clinical outcomes.
  • - Define potential impact of complications on clinical/radiographic outcomes.
  • - Determine reoperation rates over two-year follow-up period.
  • - Assess change in subaxial alignment after occiput to C2 fusion.
  • - Assess the effect of C1-2 lordosis and C1-2 fusion on subaxial alignment and outcome.
  • - Assess outcomes of long fusions involving the occiput related to head center of gravity and regional and global balance.
  • - Assess outcomes of occipital-cervical-thoracic fusion on cervical alignment and global alignment.
  • - Evaluate clinical outcomes (short- and long-term) following cervical deformity surgery.
  • - Assess cost-effectiveness of adult cervical deformity surgery.
  • - Correlate different measures of frailty, including Edmonton, CHSA, and ISSG.

Arms & Interventions

Arms

: Operative

Inclusion Criteria: 1. ≥18 years old at time of treatment 2. Patient undergoing a posterior cervical instrumented fusion using the DePuy Synthes SymphonyTM OCT System for the treatment of adult cervical deformity, defined as any of below criteria: 1. Loss of cervical lordosis (≤ 0° cervical lordosis C2-7) 2. ≥ 5° of kyphosis across any 1 or 2 cervical segments 3. ≥ 10° of cervical scoliosis 4. C2-C7 SVA ≥ 4cm 5. T1 Slope minus Cervical Lordosis ≥ 20° 6. Grade I or greater Spondylolisthesis at any segment C1-T1 7. Horizontal Gaze ≤ 0 or ≥ 11 3. Plan for surgical correction of cervical deformity in the next 6 months 4. Willing to provide consent and complete study forms at baseline and follow-up intervals Exclusion Criteria: 1. Active spine tumor or infection 2. Deformity due to acute trauma 3. Unwilling to provide consent or to complete study forms 4. Prisoner 5. Pregnant or immediate plans to get pregnant

Interventions

Device: - Symphony OCT System

Surgical intervention will be patient specified by treating surgeon.

Contact a Trial Team

If you are interested in learning more about this trial, find the trial site nearest to your location and contact the site coordinator via email or phone. We also strongly recommend that you consult with your healthcare provider about the trials that may interest you and refer to our terms of service below.

University of California Davis, Sacramento 5389489, California 5332921

Status

Active, not recruiting

Address

University of California Davis

Sacramento 5389489, California 5332921, 95817

Denver 5419384, Colorado 5417618

Status

Recruiting

Address

Denver International Spine Center, Rocky Mountain Hospital for Children and Presbyterian St. Luke's Medical Center

Denver 5419384, Colorado 5417618, 80128

Site Contact

Breton Line, BS

[email protected]

303-762-3472

University of Michigan, Ann Arbor 4984247, Michigan 5001836

Status

Withdrawn

Address

University of Michigan

Ann Arbor 4984247, Michigan 5001836, 48109

Washington University, St Louis 4407066, Missouri 4398678

Status

Recruiting

Address

Washington University

St Louis 4407066, Missouri 4398678, 63110

Site Contact

Alison Hageman

[email protected]

540-421-3101

Duke University, Durham 4464368, North Carolina 4482348

Status

Not yet recruiting

Address

Duke University

Durham 4464368, North Carolina 4482348, 27710

Site Contact

Ronald Pegues

[email protected]

540-421-3101

University of Pittsburgh Medical Center, Pittsburgh 5206379, Pennsylvania 6254927

Status

Recruiting

Address

University of Pittsburgh Medical Center

Pittsburgh 5206379, Pennsylvania 6254927, 15219

Site Contact

Lauren Puccio

[email protected]

540-421-3101

University of Virginia, Charlottesville 4752031, Virginia 6254928

Status

Recruiting

Address

University of Virginia

Charlottesville 4752031, Virginia 6254928, 22908

Site Contact

Lorrie Sipe

[email protected]

434-924-8775